嘉美包裝(002969.SZ):三片罐是80億罐上下的產能
格隆匯7月18日丨有投資者向嘉美包裝(002969.SZ)提問:公司幾個業務板塊目前的產能情況?
嘉美包裝回復:目前沒有太大變化。三片罐是80億罐上下的產能。灌裝是43億多包/瓶/罐的產能,兩片罐是目前成熟的是10億,鷹潭項目計劃16億罐,目前訂單充足的話能做到10億,還有一條國產生產線在試生產測試階段,目前算20億罐的兩片罐產能。無菌紙包原有的國產設備在27億包左右的產能,隨着明年進口線的投產會增加40-50億包的產能。上半年公司關閉了PET及其灌裝業務,因為經過十多年的測試驗證,可能PET還不太適合代工這種模式,但PET類業務原來所佔的比重就非常小。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.